New Jersey-based Campus Eye Management just made history — though not the kind most companies chase. On Wednesday, it became the first healthcare company to walk away with a declination of criminal charges under the U.S. Department of Justice's newly minted corporate enforcement policy, a legal escape hatch that few companies ever get to use.

But while the company itself dodged prosecution, the same day brought a very different outcome for its founder. The DOJ unsealed a seven-count criminal indictment in New Jersey against E. Bruce DiDonato, an optometrist accused of masterminding a fraudulent billing and kickback scheme that ran for years right under regulators' noses.

The Allegations Against DiDonato

A Scheme Years in the Making

According to prosecutors, DiDonato, 71, of Princeton, conspired to bill Medicare and private insurers for diagnostic eye tests that patients never actually needed — and to funnel illegal kickbacks to surgeons who kept the referral pipeline flowing. The DOJ says the scheme stretched from at least 2015 through March 2023, unfolding quietly across nearly a decade.

What makes the allegations particularly striking is that the tests themselves were essentially theater. The DOJ said the exams "were not reviewed by DiDonato or any optometrist, and in most instances the ophthalmologists did not review or rely on the tests to inform their treatment decisions in advance of surgery" — tests ordered, billed and then apparently forgotten, like paperwork generated purely to justify a paycheck.

Millions in Claims, Millions in Profit

Prosecutors allege DiDonato orchestrated roughly $3.4 million in fraudulent Medicare claims, with about $1 million of that actually paid out. The story doesn't end there, though — the DOJ says DiDonato later turned around and marketed Campus Eye to private equity investors, leaning in part on those very same lucrative Medicare reimbursements to make the company look more attractive on paper than its practices actually justified.

Why the Company Itself Avoided Charges

The DOJ said its decision to decline healthcare fraud charges against Campus Eye and its parent, Campus Eye Management Holdings LLC, rested on several factors working in the company's favor: it self-disclosed the alleged misconduct in a timely manner, cooperated fully with investigators, and showed a genuine willingness to overhaul its compliance policies going forward — the kind of proactive housecleaning regulators say they want to reward, not punish.

As part of the resolution, Campus Eye also agreed to pay $1 million in restitution to those harmed by the alleged scheme. The company describes itself on its own website as "one of the largest, most prestigious free-standing eye care centers in the country" — a reputation now shadowed by its founder's alleged conduct even as the business itself avoids formal charges.

Attempts to reach representatives for both Campus Eye and DiDonato were not immediately successful.

A Test Case for a New DOJ Strategy

The Policy Behind the Decision

This case marks the very first healthcare declination under a DOJ-wide corporate enforcement policy unveiled in March, part of a longstanding carrot-and-stick strategy aimed at nudging companies toward voluntary self-disclosure rather than concealment.

"The department's policies afford companies that take responsibility for their misconduct with a clear path to a declination. Businesses that ignore the law and profit from their executive's lies and deceit will be held accountable," said Assistant Attorney General Colin M. McDonald, who leads the DOJ's newly formed National Fraud Enforcement Division — a statement that draws a sharp line between companies that come clean and executives who don't.

Not the First, But a Milestone Nonetheless

While Campus Eye is the first healthcare company to benefit from this specific new policy, it's actually the second declination overall in a criminal healthcare fraud investigation, according to the DOJ. The first belonged to HealthSun Health Plans Inc., a Florida-based Medicare benefits provider that secured its own declination back in 2023 by self-reporting suspected wrongdoing, cooperating through a years-long investigation into alleged fraudulent billing, and ultimately agreeing to pay $53 million in restitution — a far steeper price tag than Campus Eye's settlement.

A Banner Year for Healthcare Fraud Enforcement

The DOJ's Health Care Fraud Unit Strike Force has already closed four criminal enforcement actions so far this year, matching a record set just last year — a pace that suggests fraud crackdowns are accelerating rather than slowing down.

Among the year's biggest cases, insurance brokerage AP of South Florida LLC agreed in April to pay $27.6 million in restitution and pleaded guilty to fraudulently enrolling thousands of people in Affordable Care Act health plans — another data point in what's shaping up to be an aggressive stretch for federal healthcare fraud enforcement.